ELAVL1 and prostate carcinoma: The highly expressed METTL3 reduces the ELAVL1 protein level by inducing the degradation of ELAVL1 protein in PCa cells and increases the expression of downstream invasion and migration-related protein ARHGDIA, and significantly upregulates the mRNA level, thus promoting the proliferation and migration of prostate cancer [26].